Development of vaginal microbicides for the prevention of heterosexual transmission of HIV
- PMID: 8603257
- DOI: 10.1097/00042560-199603010-00001
Development of vaginal microbicides for the prevention of heterosexual transmission of HIV
Abstract
Various compounds could be considered to be vaginal microbicides, preventing heterosexual transmission of HIV (i.e. virucidal agents such as nonoxynol 9 and chlorhexidine) and antiviral agents interfering with either virus adsorption/fusion [polyanionic substances such as polysulfates (i.e. PVAS, PAVAS), polysulfonates, polycarboxylates, polyoxometalates and negatively charged albumins], or fusion/uncoating (bicyclams), or reverse transcription [dideoxynucleoside analogues, acyclic nucleoside phosphonates such as PMEA and PMPA, and non-nucleoside reverse transcriptase inhibitors (NNRTIs) such as TIBO, HEPT, and alpha-APA derivatives]. In particular, combination of two or more of these compounds seems to be an attractive approach to interrupt transmission of HIV at different stages of the infectious process.
Similar articles
-
Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.Biomed Pharmacother. 1996;50(5):207-15. doi: 10.1016/0753-3322(96)87660-8. Biomed Pharmacother. 1996. PMID: 8949401 Review.
-
Antiviral therapy for human immunodeficiency virus infections.Clin Microbiol Rev. 1995 Apr;8(2):200-39. doi: 10.1128/CMR.8.2.200. Clin Microbiol Rev. 1995. PMID: 7542558 Free PMC article. Review.
-
Clinical development of microbicides for the prevention of HIV infection.Curr Pharm Des. 2004;10(3):315-36. doi: 10.2174/1381612043386374. Curr Pharm Des. 2004. PMID: 14754390 Review.
-
New developments in anti-HIV chemotherapy.Curr Med Chem. 2001 Nov;8(13):1543-72. doi: 10.2174/0929867013371842. Curr Med Chem. 2001. PMID: 11562282 Review.
-
New perspectives for the chemotherapy and chemoprophylaxis of AIDS (acquired immune deficiency syndrome).Verh K Acad Geneeskd Belg. 1992;54(1):57-88; discussion 88-9. Verh K Acad Geneeskd Belg. 1992. PMID: 1636322 Review.
Cited by
-
Virucidal agents in the eve of manorapid synergy.GMS Krankenhhyg Interdiszip. 2007 Sep 13;2(1):Doc18. GMS Krankenhhyg Interdiszip. 2007. PMID: 20200679 Free PMC article.
-
Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.J Virol. 1997 Apr;71(4):3023-30. doi: 10.1128/JVI.71.4.3023-3030.1997. J Virol. 1997. PMID: 9060662 Free PMC article.
-
Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection.Int J Nanomedicine. 2012;7:5007-18. doi: 10.2147/IJN.S34973. Epub 2012 Sep 24. Int J Nanomedicine. 2012. PMID: 23049252 Free PMC article.
-
Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission.Retrovirology. 2010 Apr 26;7:37. doi: 10.1186/1742-4690-7-37. Retrovirology. 2010. PMID: 20420669 Free PMC article.
-
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.Antimicrob Agents Chemother. 1997 Jul;41(7):1521-30. doi: 10.1128/AAC.41.7.1521. Antimicrob Agents Chemother. 1997. PMID: 9210678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical